Dexcom G7 receives CE Mark – Next-generation continuous glucose monitoring system to revolutionize diabetes management
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark ...
Source: antaranews.com